A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. The single vaccine for COVID-19, influenza andrespiratory syncytial virus—a common virus that causes the ...
Moderna said it is looking at whether a booster shot – either of its existing vaccine or of a new shot designed to protect against the South Africa variant – could be made available in future if evidence were to emerge that protection against the virus deteriorated over time....
Moderna launches COVID booster campaignHollan, MikePatient Care (Online)
Moderna is gearing up to halve the dose of its COVID-19 vaccine, the US drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children. It has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen,...
Sep 11, 2023ApprovalModerna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Dec 8, 2022Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age ...
CAMBRIDGE (CBS) -- The FDA on Fridayauthorized Moderna and Pfizer's COVID vaccine booster shotsfor all adults 18 and older. A few hours later, CDC vaccine advisers voted unanimously to recommend allowing the booster shots for all, and CDC Director Rochelle Walensky endorsed the advisory committe...
导语:近日,美国食品药品监督管理局(FDA)和疾病控制与预防中心(CDC)指控Moderna在其二价新冠疫苗的批准过程中隐瞒数据。FDA和CDC多名顾问表示:“对Moderna的这一行为表示愤怒和失望!为了获得纳税人的50亿美元订单,Moderna隐瞒了接种二价疫苗的研究...
After some of the CDC's advisers voiced concerns over Moderna's decision to use one vial for two different dose sizes, the company defended the move by citing the need to roll out booster shots in "the context of the pandemic." The company was still mulling changes to the vaccine's pack...
During anAxios COVID-19 vaccine eventon May 19, both the CEO of Moderna and the CEO of Pfizer said that depending on the research being done on the efficacy and longevity of the vaccines, a booster shot could be needed between either eight to 12 months after the recipient’s initial...